{"id":272310,"date":"2002-11-15T09:38:00","date_gmt":"2002-11-15T14:38:00","guid":{"rendered":"https:\/\/www.investmentexecutive.com\/uncategorized\/co-operators-general-reports-third-quarter-loss\/"},"modified":"2002-11-15T09:38:00","modified_gmt":"2002-11-15T14:38:00","slug":"co-operators-general-reports-third-quarter-loss","status":"publish","type":"post","link":"https:\/\/www.investmentexecutive.com\/news\/industry-news\/co-operators-general-reports-third-quarter-loss\/","title":{"rendered":"Co-operators General reports third-quarter loss"},"content":{"rendered":"
Co-operators General Insurance Co. is reporting a after-tax loss of $3,364,000 for the third quarter ended September 30, compared to a profit of $267,000 during the same period in 2001.
“Escalating costs associated with serious bodily injury claims continue to depress earnings despite double-digit premium rate increases. The situation is not helped by limited investment yields in the current volatile markets,” said Kathy Bardswick, Co-operators president and CEO, in a news release. “We are encouraged by the improvement in year-to-date financial results over 2001.”
Gross written premium in the third quarter increased 8.1% to $480 million, compared to $444 million in the third quarter of 2001. The claims ratio for the quarter was 80.9%, compared to 86.4% during the comparable period last year. The combined ratio of claims and operating expenses was 108.9%, compared to 112.7% for the third quarter of 2002. The underwriting results have improved $12 million from the third quarter a year ago.
Gross written premium on a year-to-date basis was $1.3 billion, reflecting an increase of 6.5% over last year. Earned premium growth was 5.6% above the previous year. A net profit of $1.4 million was recorded for the nine months ended September 30, 2002, compared to a net loss of $8.2 million for the comparable nine month period in 2001. Investment income at $94.5 million decreased 8.6% from the $103.4 million reported for 2001.
<\/p>\n","protected":false},"excerpt":{"rendered":"
Escalating costs continue to depress earnings<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[2312,2318],"tags":[2483],"yst_prominent_words":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.investmentexecutive.com\/wp-json\/wp\/v2\/posts\/272310"}],"collection":[{"href":"https:\/\/www.investmentexecutive.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.investmentexecutive.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.investmentexecutive.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.investmentexecutive.com\/wp-json\/wp\/v2\/comments?post=272310"}],"version-history":[{"count":0,"href":"https:\/\/www.investmentexecutive.com\/wp-json\/wp\/v2\/posts\/272310\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.investmentexecutive.com\/wp-json\/wp\/v2\/media?parent=272310"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.investmentexecutive.com\/wp-json\/wp\/v2\/categories?post=272310"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.investmentexecutive.com\/wp-json\/wp\/v2\/tags?post=272310"},{"taxonomy":"yst_prominent_words","embeddable":true,"href":"https:\/\/www.investmentexecutive.com\/wp-json\/wp\/v2\/yst_prominent_words?post=272310"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}